EDGAR Filing Documents for 0001193125-17-231628

Form 8-K - Current report:

SEC Accession No. 0001193125-17-231628

Filing Date

2017-07-20

Accepted

2017-07-20 07:02:32

Documents

Period of Report

2017-07-19

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d424837d8k.htm	8-K	27841
2	EX-99.1	d424837dex991.htm	EX-99.1	27250
3	EX-99.2	d424837dex992.htm	EX-99.2	27408
4	EX-99.3	d424837dex993.htm	EX-99.3	9192
5	GRAPHIC	g424837g41x77.jpg	GRAPHIC	3902
	Complete submission text file	0001193125-17-231628.txt		98627

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301

Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700

Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)